Literature DB >> 34034644

Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.

Timothy R Smith1, Egilius L H Spierings2, Roger Cady3, Joe Hirman4, Barbara Schaeffler5, Vivienne Shen6, Bjørn Sperling7, Thomas Brevig7, Mette Krog Josiassen7, Elizabeth Brunner6, Loan Honeywell7, Lahar Mehta5.   

Abstract

Entities:  

Year:  2021        PMID： 34034644     DOI： 10.1186/s10194-021-01253-3

Source DB:  PubMed          Journal:  J Headache Pain        ISSN： 1129-2369            Impact factor:   7.277


× No keyword cloud information.
  1 in total

1.  Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.

Authors:  Timothy R Smith; Egilius L H Spierings; Roger Cady; Joe Hirman; Barbara Schaeffler; Vivienne Shen; Bjørn Sperling; Thomas Brevig; Mette Krog Josiassen; Elizabeth Brunner; Loan Honeywell; Lahar Mehta
Journal:  J Headache Pain       Date:  2021-03-30       Impact factor: 7.277
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.